基于结构方程模型的药品集团采购供应链韧性影响因素研究

Research on Influencing Factors of Resilience of Pharmaceutical Group Procurement Supply Chain Based on Structural Equation Model

摘要: 目的：中国药品政策的变化与自然环境的不确定性对药品集团采购供应链的稳定运行带来了极大挑战，如何提升韧性成为我国药品集团采购供应链持续发展亟待解决的关键问题。方法：本文以TOE框架为基础，构建影响因素研究模型，以356份有效数据样本，采用结构方程模型(SEM)进行实证分析。结果：研究发现影响药品集团采购供应链韧性的技术因素(数字化应用能力、技术驱动能力)与组织因素(获取能力、整合能力、感知能力)与环境因素(制度环境)存在显著相关性，且均为正向相关。结论：药品GPO供应链企业可从技术、组织和环境三个方面出发共同促进药品集团采购供应链韧性的增强。

Abstract: Objective: The changes in China’s drug policy and the uncertainty of the natural environment have brought great challenges to the stable operation of the procurement supply chain of pharmaceutical groups, and how to improve resilience has become a key issue to be solved for the sustainable development of the procurement supply chain of pharmaceutical groups in China. Methods: Based on the TOE framework, this paper constructed a research model of influencing factors, and empirically analyzed 356 valid data samples by structural equation model (SEM). Results: The study found that there was a significant correlation between the technical factors (digital application ability, technology-driven ability) and organizational factors (acquisition ability, integration ability, perception ability) and environmental factors (institutional environment) that affect the resilience of the procurement supply chain of pharmaceutical groups, and all of them were positively correlated. Conclusion: Pharmaceutical GPO supply chain enterprises can jointly promote the enhancement of the resilience of pharmaceutical group procurement supply chain from three aspects: technology, organization and environment.